MTE #16: Cannabis and Cannabidiol Hepatotoxicity (Ticketed)

Nov 17 2024
Convention Center: Room 33 B
7:00 AM - 7:45 AM
Ticketed Event

World Class Speakers

Melissa Palmer, MD
Discussion Leader

Melissa Palmer, MD

CEO Liver Consulting LLC
Raj Vuppalanchi, MD, FAASLD
Discussion Leader

Raj Vuppalanchi, MD, FAASLD

Indiana University School of Medicine

Description

Speakers discuss the data regarding hepatotoxicity from cannabis and cannabidiol compounds.

Journey Maps

Objectives

  • Explain the liver toxicity risk associated with cannabis products.
  • Describe the difference between cannabidiol (CBD) and cannabis in terms of liver injury and relative toxicity.